Trace amine-associated receptor 1 modulation of dopamine system

Research output: Chapter in Book/Report/Conference proceedingChapterpeer-review

Abstract

Trace amine-associated receptor 1 (TAAR1) is a G-protein-coupled receptor belonging to the TAAR family. Discovered in 2001, TAARs have been found in several tissues, ranging from the central nervous system to the olfactory epithelium. The best-studied receptor, TAAR1, is activated by a class of endogenous compounds named trace amines (TAs). TAs are structurally related to classic monoaminergic neurotransmitters and found at low concentrations in the mammalian brain. Although TA levels have been associated with many neuropsychiatric disorders, only the discovery of TAAR1 validated their physiological role. TAAR1 can modulate monoamine neurotransmission and, in particular, the dopamine system. Several studies have demonstrated that TAAR1 knockout mice display a supersensitive dopaminergic system, while activation of TAAR1 can reduce dopaminergic hyperactivity. For these reasons, TAAR1 has been proposed as a novel therapeutic target for neuropsychiatric disorders such as schizophrenia, bipolar disorder, and addiction.

Original languageEnglish
Title of host publicationTrace Amines and Neurological Disorders
Publication statusPublished - 2016

Fingerprint

Dive into the research topics of 'Trace amine-associated receptor 1 modulation of dopamine system'. Together they form a unique fingerprint.

Cite this